July 2026 - Gold producer Native Mineral Resources Holdings Limited (ASX: NMR) has entered its third convertible security ...

July 2026 - ASX-listed graphite developer demands completion by 9 July after buyer fails to finalise acquisition.

July 2026 - The radiopharmaceutical firm achieves 11% revenue growth and expands US footprint, but clinical guideline ...

Australia’s sharemarket is experiencing a significant surge in new exchange-traded funds (ETFs), with 72 new products hitting the boards in the 2026 financial year – a record high, up from 50 in the ...

July 2026 - Deputy Portfolio Manager Joe Wright reveals fund's underweight to banks and new opportunities in industrials.

July 2026 - Conditions precedent for the proposed earn-in and joint venture agreement were not satisfied by the required date.

July 2026 - ASX-listed B2B funder Butn Limited divests Smash Repair Factoring Business for $4.1 million and amends corporate credit facility to streamline operations and reduce costs.

July 2026 - ASX-listed BCAL Diagnostics invests $1.39 million for 10.2% of molecular diagnostics firm, aiming to expand market reach and leverage complementary capabilities.

July 2026 - The radiopharmaceutical company gains regulatory clearance to advance Part 2 of its ProstACT Global Phase 3 study for TLX591-Tx in metastatic castration-resistant prostate cancer.

July 2026 - Australian healthcare company invests $1.39 million for 10.2% of molecular diagnostics firm to expand market reach and product synergy.

July 2026 - Profit-taking in semiconductor stocks offsets strength in industrials as investors await key US jobs data.

July 2026 - ASX-listed entity forms diversified financial services powerhouse, pending shareholder approval for Barrenjoey ...